BR
About
BridgeBio is a biotechnology company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. BridgeBio creates a bridge from advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. BridgeBio's mission is to discover, create, test, and deliver transformative medicines to treat patients with genetic diseases.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 931 investors are based in Palo Alto, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Palo Alto, US
Contact Information
Find more investors like BridgeBio
Search Investors